Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 3, 2006, Pages 269-273

  Kumaran, M S ^a   Kaur, I ^a   Kumar, Bhushan ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Betamethasone dipropionate; Calcipotriol; Localized vitiligo

Indexed keywords

BETAMETHASONE DIPROPIONATE; CALCIPOTRIOL;

ADULT; ARTICLE; BURNING SENSATION; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG MECHANISM; DRUG RESPONSE; DRY SKIN; FEMALE; HUMAN; HYPERTRICHOSIS; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN ATROPHY; SKIN PIGMENTATION; TREATMENT OUTCOME; VITILIGO;

ADMINISTRATION, CUTANEOUS; ADULT; BETAMETHASONE; CALCITRIOL; DERMATOLOGIC AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; OINTMENTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VITILIGO;

EID: 33646006687     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01420.x     Document Type: Article

References (18)

1. Koranne RV, Sachdeva KG. Vitiligo. Int J Dermatol 1988; 27: 676-680.
2. Kumari J. Vitiligo treated with topical clobetasol propionate. Arch Dermatol 1984; 120: 631-635.
3. Njoo MD, Spuls PI, Bos JD. Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature. Arch Dermatol 1998; 134: 1532-1540.
4. Glaser R, Rowert J, Mrowlet Z. Hyperpigmentation due to topical calcipotriol and photochemotherapy in two psoriasis patients. Br J Dermatol 1998; 139: 148-151.
5. Prasad D, Saini R, Nagpal R. Calcipotriol in vitiligo. Pediatr Dermatol 1999; 16: 317-320.
6. Prasad D, Saini R, Verma N. Combination of PUVAsol and topical calcipotriol in vitiligo. Dermatology 1998; 197: 167-170.
7. Bleehan SS. The treatment of vitiligo with topical corticosteroid light and electron microscopic studies. Br J Dermatol 1976; 94: 43-50.
8. Kandil E. Vitiligo: Response to 0.2% betamethasone 17-valerate in flexible collodion. Dermatologica 1970; 141: 277-281.
9. Kandil E. Treatment of vitiligo with 0.1% BV in isopropyl alcohol -a double-blind trial. Br J Dermatol 1974; 91: 457-460.
10. Hann SK, Park YK (eds). New concepts in vitiligo. Clin Dermatol 1997; 15: 835-841.
11. Mosher DB, Fitzpatrick TB, Horiy J, Ortonne JP. Disorders of pigmentation. In: Fitzpatrick TB, Eisen AJ, Wolff K, Freedberg IM, Austen KP, eds. Dermatology in General Medicine, Vol. 1, 5th edn. McGraw-Hill, New York, 1999: 936-950.
12. Tomita Y, Tormiki W, Togami H. Stimulation of human melanocytes by vitamin D3 possibly mediates skin pigmentation after sun exposure. J Invest Dermatol 1988; 90: 882-884.
13. Milde P, Hauser U, Simon T et al. Expression of 1,25-dihydroxy vitamin D3 receptors in normal and psoriatic skin. J Invest Dermatol 1991; 97: 230-239.
14. Ameen M, Exarchou V, Chu AC. Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in treatment of vitiligo. Br J Dermatol 2001; 145: 476-479.
15. Cunningham BB, Landells IDR, Langman C et al. Topical calcipotriene for morphea/linear scleroderma. J Am Acad Dermatol 1998; 39: 211-215.
16. Kreuter A, Gambichler T, Sauermann K et al. Extragenital lichen sclerosis successfully treated with topical calcipotriol: Evaluation in vivo by confocal laser scanning microscopy. Br J Dermatol 2002; 146: 332-333.
17. Ruzicka T, Lorenz B. Calcipotriol with or without betamethasone for psoriasis. Br J Dermatol 1997; 138: 254-258.
18. Lebwohl M, Siskin SB, Epinette W et al. A multicentre trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis. J Am Acad Dermatol 1996; 35: 268-269.